Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma von Norden, Andrew D, Ligon, Keith L, Hammond, Samantha N, Muzikansky, Alona, Reardon, David A, Kaley, Thomas J, Batchelor, Tracy T, Plotkin, Scott R, Raizer, Jeffrey J, Wong, Eric T, Drappatz, Jan, Lesser, Glenn J, Haidar, Sam, Beroukhim, Rameen, Lee, Eudocia Q, Doherty, Lisa, Lafrankie, Debra, Gaffey, Sarah C, Gerard, Mary, Smith, Katrina H, McCluskey, Christine, Phuphanich, Surasak, Wen, Patrick Y

Volltext

Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas von Norden, Andrew D., Schiff, David, Ahluwalia, Manmeet S., Lesser, Glenn J., Nayak, Lakshmi, Lee, Eudocia Q., Rinne, Mikael L., Muzikansky, Alona, Dietrich, Jorg, Purow, Benjamin, Doherty, Lisa M., LaFrankie, Debra C., Pulverenti, Julee R., Rifenburg, Jennifer A., Ruland, Sandra F., Smith, Katrina H., Gaffey, Sarah C., McCluskey, Christine, Ligon, Keith L., Reardon, David A., Wen, Patrick Y.

Volltext

Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma von Lee, Eudocia Q, Duda, Dan G, Muzikansky, Alona, Gerstner, Elizabeth R, Kuhn, John G, Reardon, David A, Nayak, Lakshmi, Norden, Andrew D, Doherty, Lisa, LaFrankie, Debra, Stefanik, Jennifer, Vardam, Trupti, Smith, Katrina H, McCluskey, Christine, Gaffey, Sarah, Batchelor, Tracy T, Jain, Rakesh K, Wen, Patrick Y

Volltext

A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients von Lee, Eudocia Q, Kaley, Thomas J, Duda, Dan G, Schiff, David, Lassman, Andrew B, Wong, Eric T, Mikkelsen, Tom, Purow, Benjamin W, Muzikansky, Alona, Ancukiewicz, Marek, Huse, Jason T, Ramkissoon, Shakti, Drappatz, Jan, Norden, Andrew D, Beroukhim, Rameen, Weiss, Stephanie E, Alexander, Brian M, McCluskey, Christine S, Gerard, Mary, Smith, Katrina H, Jain, Rakesh K, Batchelor, Tracy T, Ligon, Keith L, Wen, Patrick Y

Volltext

Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma von Lee, Eudocia Q, Reardon, David A, Schiff, David, Drappatz, Jan, Muzikansky, Alona, Grimm, Sean A, Norden, Andrew D, Nayak, Lakshmi, Beroukhim, Rameen, Rinne, Mikael L, Chi, Andrew S, Batchelor, Tracy T, Hempfling, Kelly, McCluskey, Christine, Smith, Katrina H, Gaffey, Sarah C, Wrigley, Brendan, Ligon, Keith L, Raizer, Jeffrey J, Wen, Patrick Y

Volltext

A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy von Lee, Eudocia Q, Muzikansky, Alona, Drappatz, Jan, Kesari, Santosh, Wong, Eric T, Fadul, Camilo E, Reardon, David A, Norden, Andrew D, Nayak, Lakshmi, Rinne, Mikael L, Alexander, Brian M, Arvold, Nils D, Doherty, Lisa, Stefanik, Jennifer, LaFrankie, Debra, Ruland, Sandra F, Pulverenti, Julee, Smith, Katrina H, Gaffey, Sarah C, Hammond, Samantha, Wen, Patrick Y

Volltext

Phase II trial of triple-receptor tyrosine kinase receptor inhibitor nintedanib (BIBF 1120) in recurrent high-grade gliomas von Norden, Andrew David, Schiff, David, Ahluwalia, Manmeet Singh, Lesser, Glenn Jay, Nayak, Lakshmi, Lee, Eudocia Quant, Muzikansky, Alona, Dietrich, Jorg, Smith, Katrina H., Gaffey, Sarah C., McCluskey, Christine Sceppa, Ligon, Keith L., Reardon, David A., Wen, Patrick Y.

Volltext

Panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma von Lee, Eudocia Quant, Reardon, David A., Schiff, David, Drappatz, Jan, Muzikansky, Alona, Grimm, Sean Aaron, Norden, Andrew David, Nayak, Lakshmi, Beroukhim, Rameen, Rinne, Mikael L., Chi, Andrew S., Batchelor, Tracy, Hempfling, Kelly, McCluskey, Christine Sceppa, Smith, Katrina H., Gaffey, Sarah C., Wrigley, Brendan, Raizer, Jeffrey J., Wen, Patrick Y.

Volltext

A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy von Lee, Eudocia Quant, Muzikansky, Alona, Kesari, Santosh, Wong, Eric T., Fadul, Camilo E., Reardon, David A., Norden, Andrew David, Nayak, Lakshmi, Rinne, Mikael L., Alexander, Brian Michael, Arvold, Nils D., Doherty, Lisa M., LaFrankie, Debra C., Pulverenti, Julee, Smith, Katrina H., Gaffey, Sarah C., Hammond, Samantha, Drappatz, Jan, Wen, Patrick Y.

Volltext

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma: Final results von Norden, Andrew David, Drappatz, Jan, Phuphanich, Surasak, Reardon, David A., Wong, Eric T., Plotkin, Scott Randall, Kaley, Thomas Joseph, Raizer, Jeffrey J., Lesser, Glenn Jay, Batchelor, Tracy, Lee, Eudocia Quant, Beroukhim, Rameen, Muzikansky, Alona, Doherty, Lisa M., LaFrankie, Debra C., Ruland, Sandra, Smith, Katrina H., Gerard, Mary, McCluskey, Christine Sceppa, Wen, Patrick Y.

Volltext

Phase I study of plerixafor and bevacizumab in recurrent high-grade glioma von Smith, Katrina H., Lee, Eudocia Quant, Muzikansky, Alona, Gerstner, Elizabeth Robins, Duda, Dan G., Reardon, David A., Nayak, Lakshmi, Norden, Andrew David, Doherty, Lisa M., Rifenburg, Jennifer, LaFrankie, Debra C., Ruland, Sandra, Pulverenti, Julee, Stokes, Deirdre, Lam, Priscilla, McCluskey, Christine Sceppa, Gaffey, Sarah C., Batchelor, Tracy, Jain, Rakesh K., Wen, Patrick Y.

Volltext

Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas: Final results von Norden, Andrew David, Schiff, David, Ahluwalia, Manmeet Singh, Lesser, Glenn Jay, Nayak, Lakshmi, Lee, Eudocia Quant, Rinne, Mikael L., Muzikansky, Alona, Dietrich, Jorg, Purow, Benjamin, Smith, Katrina H., Gaffey, Sarah C., McCluskey, Christine Sceppa, Ligon, Keith L., Reardon, David A., Wen, Patrick Y.

Volltext

Phase II Study of Monthly Pasireotide LAR (SOM230C) for Recurrent or Progressive Meningioma von Norden, A. D, Ligon, Keith Lloyd, Hammond, Samantha N, Muzikansky, A, Reardon, David Allen, Kaley, Thomas J, Batchelor, Tracy Todd, Plotkin, Scott, Raizer, Jeffrey J, Wong, Eric T, Drappatz, Jan, Lesser, Glenn J, Haidar, Sam, Beroukhim, Rameen, Lee, Eudocia Quant, Doherty, Lisa, Lafrankie, Debra, Gaffey, S. C, Gerard, Mary, Smith, Katrina H, McCluskey, C, Phuphanich, Surasak, Wen, Patrick Yung Chih

Volltext

Interim analysis of a phase I/II study of panobinostat in combination with bevacizumab for recurrent glioblastoma von Lee, Eudocia Quant, Reardon, David A., Schiff, David, Drappatz, Jan, Muzikansky, Alona, Hammond, Samantha, Grimm, Sean Aaron, Norden, Andrew David, Beroukhim, Rameen, McCluskey, Christine Sceppa, Chi, Andrew S., Batchelor, Tracy, Smith, Katrina H., Gaffey, Sarah C., Gerard, Mary, Snodgrass, Susan M., Raizer, Jeffrey J., Wen, Patrick Y.

Volltext

Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival von Guilhamon, Paul, Chesnelong, Charles, Kushida, Michelle M., Nikolic, Ana, Singhal, Divya, MacLeod, Graham, Tonekaboni, Seyed Ali Madani, Cavalli, Florence M. G., Arlidge, Christopher, Rajakulendran, Nishani, Rastegar, Naghmeh, Hao, Xiaoguang, Hassam, Rozina, Smith, Laura J., Whetstone, Heather, Coutinho, Fiona J., Nadorp, Bettina, Ellestad, Katrina, Luchman, H. Artee, Chan, Jennifer Ai-wen, Shoichet, Molly S., Taylor, Michael D., Haibe-Kains, Benjamin, Weiss, Samuel, Angers, Stephane, Gallo, Marco, Dirks, Peter B., Lupien, Mathieu

Volltext

Food protein–induced enterocolitis syndrome in Australia: A population-based study, 2012-2014 von Mehr, Sam, MD, FRACP, Frith, Katie, MD, FRACP, Barnes, Elizabeth H., BAppSc, MStat, Campbell, Dianne E., MD, PhD

Volltext

The Impact of Rapid Exome Sequencing on Medical Management of Critically Ill Children von Freed, Amanda S., Clowes Candadai, Sarah V., Sikes, Megan C., Thies, Jenny, Byers, Heather M., Dines, Jennifer N., Ndugga-Kabuye, Mesaki Kenneth, Smith, Mallory B., Fogus, Katie, Mefford, Heather C., Lam, Christina, Adam, Margaret P., Sun, Angela, McGuire, John K., DiGeronimo, Robert, Dipple, Katrina M., Deutsch, Gail H., Billimoria, Zeenia C., Bennett, James T.

Volltext

Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care von Lee, Peter A., Nordenström, Anna, Houk, Christopher P., Ahmed, S. Faisal, Auchus, Richard, Baratz, Arlene, Baratz Dalke, Katharine, Liao, Lih-Mei, Lin-Su, Karen, Looijenga 3rd, Leendert H.J., Mazur, Tom, Meyer-Bahlburg, Heino F.L., Mouriquand, Pierre, Quigley, Charmian A., Sandberg, David E., Vilain, Eric, Witchel, Selma

Volltext

Network analysis of epidermal growth factor signaling using integrated genomic, proteomic and phosphorylation data von Waters, Katrina M, Liu, Tao, Quesenberry, Ryan D, Willse, Alan R, Bandyopadhyay, Somnath, Kathmann, Loel E, Weber, Thomas J, Smith, Richard D, Wiley, H Steven, Thrall, Brian D

Volltext

Grandmaster level in StarCraft II using multi-agent reinforcement learning von Vinyals, Oriol, Babuschkin, Igor, Czarnecki, Wojciech M., Mathieu, Michaël, Dudzik, Andrew, Chung, Junyoung, Choi, David H., Powell, Richard, Ewalds, Timo, Georgiev, Petko, Oh, Junhyuk, Horgan, Dan, Kroiss, Manuel, Danihelka, Ivo, Huang, Aja, Sifre, Laurent, Cai, Trevor, Agapiou, John P., Jaderberg, Max, Vezhnevets, Alexander S., Leblond, Rémi, Pohlen, Tobias, Dalibard, Valentin, Budden, David, Sulsky, Yury, Molloy, James, Paine, Tom L., Gulcehre, Caglar, Wang, Ziyu, Pfaff, Tobias, Wu, Yuhuai, Ring, Roman, Yogatama, Dani, Wünsch, Dario, McKinney, Katrina, Smith, Oliver, Schaul, Tom, Lillicrap, Timothy, Kavukcuoglu, Koray, Hassabis, Demis, Apps, Chris, Silver, David

Volltext